AptaCheck platform
care detection of infectious agents AptaCheck
FLU
point of care
lab-quality accuracy
detection of new pathogens
groundbreaking platform
new markets
new jobs
lower accuracy
biochips
Bioelectronic lab
Infectious patients
hand-held reader
Cost
aptamer-based biosensor platform
pre-clinical testing
electronic lab systems
obligatory clinical approvals
clinical microbiological departments
diagnostics sector
gastroenteritis diagnostics
infections pathogens
disposable chip
wireless communication
Turnover-time
identifications
QR scanner
system optimisation
WiFi
key strategic downstream distribution partner
scalable industrial production process
display
human samples
devices
POC
direct observation
ELISA
applications
bn market
mover advantage
supply chain
cumulative revenues
Simplicity
special equipment
skills
clinics
drug manufacturing industry
PCR
data transfer
minutes
end user
hospitals
instability
funding
antibody
drawbacks
sample handling
accurate diagnosis
Portability
state
Phase
financing
eventual outbreaks
Action
AptaChek